Skip to content

Adolescent Coordinated Transition Nigerian HIV+ Youth

Adolescent Coordinated Transition (ACT) to Improve Health Outcomes Among Nigerian HIV+ Youth

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03152006
Acronym
ACT
Enrollment
216
Registered
2017-05-12
Start date
2017-06-28
Completion date
2021-06-30
Last updated
2017-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

Healthcare transition, Adolescents, Nigeria

Brief summary

The purpose of this study is to evaluate the comparative effectiveness of a comprehensive, coordinated transition protocol which includes an early introduction to the adult provider, an integrated case management team and a peer-facilitated organized support group on retention in care, viral suppression and psychosocial wellbeing among adolescents living with HIV.

Detailed description

Using a two-arm cluster randomized design, our proposed study will evaluate the comparative effectiveness of ACT, a coordinated protocol for transitioning adolescents living with HIV (ALHIV) from pediatric to adult care (Intervention Group; IG) versus the usual abrupt transfer to adult care (Control group; CG) on rates of retention in care and viral suppression, and differences in perceived psychosocial wellbeing. Twelve health facilities, two in each of the six geopolitical zones of Nigeria will be pair-matched and randomly assigned to either IG (N=6 health facilities) or CG (N=6 health facilities). A total of 216 ALHIV will be enrolled in the study over a 36-month period. The primary outcome will be the difference in the rate of retention between the groups. Secondary outcomes will be difference in the rate of viral suppression and the difference in perceived psychosocial wellbeing. Additionally, the investigators will conduct mediation/moderation analysis to examine the role of intermediate variables such as transition readiness, perceived mental health, social support, health locus of control, self-esteem and sexual risk behavior self-efficacy on the primary outcomes. Implementation factors will be assessed using the hybrid 2 model.

Interventions

OTHERACT

Coordinated, graduated transition which includes an early introduction to the adult clinician during the PAPA pre-transfer period, a peer-facilitated organized support group aimed at improving transition readiness and addressing critical psychosocial skills including self-efficacy and locus of control and a case management team including a patient advocate who coordinates the transfer between pediatric and adult care teams.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Nevada, Las Vegas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Documented HIV infection * Aware of HIV diagnosis * Currently on ART

Exclusion criteria

* Medically unstable

Design outcomes

Primary

MeasureTime frameDescription
Retention in care in care 6 months post-transfer6 monthsProportion of participants who had at least 1 clinical visit to an HIV provider within the 6 months post-transfer
Retention in care 12 months post-transfer12 monthsProportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within the 1 year period post-transfer
Retention in care 24 months post-transfer24 monthsProportion of participants who had at least 2 clinical visits to an HIV provider separated by 6 months within a 1 year period during the second year post-transfer

Secondary

MeasureTime frameDescription
Social SupportEnrollment, baseline (12 months), 24 and 36 monthsFunctional Social Support Questionnaire
Viral SuppressionEnrollment, baseline (12 months), 24 and 36 monthsProportion of participants with undetectable viral load
Transition ReadinessEnrollment, baseline (12 months), 24 and 36 monthsTransition Readiness Assessment Questionnaire
Sexual Risk BehaviorEnrollment, baseline (12 months), 24 and 36 monthsSexual Risk Beliefs and Behavior Self Efficacy Questionnaire
Mental Health and WellbeingEnrollment, baseline (12 months), 24 and 36 monthsMental health continuum-short form Questionnaire
Health Locus of ControlEnrollment, baseline (12 months), 24 and 36 monthsHealth Locus of control / Self-esteem Questionnaire

Countries

Nigeria

Contacts

Primary ContactEchezona Ezeanolue, MD, MPH
echezona.ezeanolue@unlv.edu702-895-2687
Backup ContactNadia Sam-Agudu, MD
nsamagudu@ihvnigeria.org+2347063501205

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026